Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1b, Open-label, Boost-optimization Study of an Adenoviral- Vector Based Oral Norovirus Vaccine (VXA-G1.1-NN) Expressing GI.1 VP1 Administered Orally to Healthy Adult Volunteers

Next Previous
X
Search
Trial Profile

A Phase 1b, Open-label, Boost-optimization Study of an Adenoviral- Vector Based Oral Norovirus Vaccine (VXA-G1.1-NN) Expressing GI.1 VP1 Administered Orally to Healthy Adult Volunteers

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 24 May 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs VXA G1.1 NN (Primary)
  • Indications Norovirus infections
  • Focus Pharmacodynamics
  • Acronyms VXA-NVV-105
  • Sponsors Vaxart

    • Most Recent Events

    • 24 Feb 2022 According to a Vaxart media release, the Company expects complete data to be available in the first half of 2022.
    • 10 Jan 2022 Status changed from active, no longer recruiting to completed.
    • 04 Nov 2021 According to the Vaxart media release, the company expects initial data from this study in Q1 2022 and more complete data by Q2 2022.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top